Objectives To evaluate the efficacy of rituximab (RTX) in IgG4-related disease (IgG4-RD) in an open-label pilot trial. Methods We treated 30 IgG4-RD patients with two doses of RTX (1000 mg each). The ...

1 Department of Neurology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands 2 Department of Neurology, University Medical Centre Utrecht, Utrecht, The Netherlands ...

Correspondence to Dr Amanda M Eudy, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA; Amanda.eudy{at}duke.edu Objective Prior studies found conflicting results about ...

1 Department of Rheumatology, University Medical Centre St Radboud, Nijmegen, The Netherlands 2 Department of Rheumatology, St Maartenshospital, Nijmegen, The Netherlands 3 Department of Medical ...

Objective: To study whether formal education and occupational class are associated with incidence of rheumatoid arthritis overall and with the incidence of the two major subgroups of rheumatoid ...

5 Health Search, Italian College of General Practitioners, Florence, Italy 6 Italian College of General Practitioners, Florence, Italy Correspondence to Gianluca Trifirò, Department of Clinical and ...

Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada Correspondence to Dr B Kuriya, University of Toronto, Wolf and Lebovic Building, 60 Murray Street, Box ...

Background Anti-Ro60 and anti-Ro52 antibodies are associated with different connective tissue diseases (CTDs) [1]. However, the clinical significance of anti-Ro antibodies is not always consistent ...

Department of Medicine, Klinikum Steglitz, Free University of Berlin, Germany. OBJECTIVE--To examine whether reactive arthritis (ReA) known to occur after a urogenital infection with Chlamydia ...

SpA: Innovative techniques in spondyloarthritis research – Is there light at the end of the tunnel for our patients?

The multiple rheumatological faces of PsA (or PsA is more than just poly-arthritis? - Consequences for management in daily practice) ...

We read with interest the recent article by Singh and Cleveland on the hypersensitivity risk of allopurinol (ALP) and febuxostat (FBX) compared with colchicine.1 A common challenge when using ALP, ...